The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Suo-wen Xu, Iqra Ilyas & Jian-ping Weng Acta Pharmacologica Sinica volume 44, pages695–709 (2023) Nature Abstract The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is still raging. However, the pathophysiology of acute and post-acute […]

Potential Prophylactic Treatments for COVID-19

Noam Ben-Zuk,1,† Ido-David Dechtman,2,3,† Itai Henn,1 Libby Weiss,1 Amichay Afriat,4 Esther Krasner,1,* and Yoav Gal1,5,*Kenneth Lundstrom, Academic Editor and Alaa A. A. Aljabali, Academic Editor Viruses. 2021 Jul; 13(7): 1292. Published online 2021 Jul 2. doi: 10.3390/v13071292 PMCID: PMC8310088 PMID: 34372498 Abstract The World Health […]

Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, […]

The Role of Colchicine in Pericardial Syndromes

Authors: George Lazaros 1, Massimo Imazio 2, Antonio Brucato 3, Charalambos Vlachopoulos 1, Emilia Lazarou 1, Dimitrios Vassilopoulos 4, Dimitris Tousoulis 1PMID: 29336245 DOI: 10.2174/1381612824666180116101823 Curr Pharm Des . 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823. Abstract Background: Colchicine is an old drug originally employed for the treatment of inflammatory disorders […]